Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosis
Cancer surveillance should be particularly careful in patients with diffuse SSc, increased age at disease onset and without classical SSc-related autoantibodies.
Authors
- Francesca Motta (ORCID: https://orcid.org/0000-0002-8093-2734)
- Carlo Selmi (ORCID: https://orcid.org/0000-0002-0323-0376)
- Natasa Isailovic (ORCID: https://orcid.org/0000-0002-9819-8822)
- Stefanos Bonovas (ORCID: https://orcid.org/0000-0001-6102-6579)
- Angela Ceribelli (ORCID: https://orcid.org/0000-0001-5116-4724)
- Antonio Tonutti (ORCID: https://orcid.org/0009-0000-9534-6853)
- Emanuele Nappi (ORCID: https://orcid.org/0000-0003-1458-4863)
- Maria De Santis (ORCID: https://orcid.org/0000-0002-3196-1336)
- Rita Ragusa
Institutions
- Humanitas University (IT)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- RMD Open
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1136/rmdopen-2024-004492
- Citations
- 8
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 3.40
Funders
- Ministero della Salute
- Humanitas Research Hospital